Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Laryngeal Diseases × Ipilimumab × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 4 Uveal Melanoma 1 Skin Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Motor Activity 1 Lymphoid Interstitial Pneumonia 1 Laryngeal Diseases 1 Carcinoma, Renal Cell 1 Carcinoma, Merkel Cell 1 Brain Neoplasms 1

Interventions

Radiotherapy, Intensity-Modulated 1 Nivolumab 1 Metformin 1 Ipilimumab 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03162731 2025-04-29

Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer

Thomas Jefferson University

Phase EARLY_PHASE1 Completed

Lymphoid Interstitial Pneumonia, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡